Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder

被引:64
|
作者
Talarowska, Monika [1 ]
Galecki, Piotr [1 ]
Maes, Michael [2 ]
Orzechowska, Agata [1 ]
Chamielec, Marcelina [1 ]
Bartosz, Grzegorz [3 ,4 ]
Kowalczyk, Edward [5 ]
机构
[1] Med Univ Lodz, Dept Adult Psychiat, PL-91229 Lodz, Poland
[2] Piyavate Hosp, Maes Clin TRIA, Bangkok 10310, Thailand
[3] Med Univ Lodz, Dept Mol Biophys, PL-91229 Lodz, Poland
[4] Univ Rzeszow, Dept Biochem & Cell Biol, Rzeszow, Poland
[5] Med Univ Lodz, Dept Pharmacol & Toxicol, PL-91229 Lodz, Poland
关键词
Depression; Nitric oxide; Cognitive impairment; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SPATIAL MEMORY; HOMOCYSTEINE; DEMENTIA; DECLINE; INTERFERENCE; METABOLITES; EXPRESSION;
D O I
10.1016/j.neulet.2012.01.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/aim: Depressive disorders are multifactorial diseases, in which cognitive impairment is one of the characteristic feature. One of the molecules that regulate of various cognitive, emotional and behavioural processes is nitric oxide (NO), synthesized from L-arginine by a family of isoformic enzymes known as nitric oxide synthases (NOS). NO is a gaseous compounds that acts as a biological second messenger in a number of organ system. In addition, NO is a ubiquitous free radical ((NO)-N-center dot) that affects many normal physiologic functions but is also implicated in the etiology and progression of many diseases. The aim of the study was to determine the concentration of NO in patients with recurrent depressive disorder (rDD) and to define relationship between plasma NO levels and the cognitive performance. Methods: The study comprised 78 subjects: patients with rDD (n = 45), healthy controls (CG, n = 33). Cognitive function assessment was based on: TMT, The Stroop Test, VFT, AVLT. Results: Statistically significant differences were found among patients with rDD in the intensity of depression symptoms, measured by the HORS on therapy onset vs. the examination results after 8 weeks of treatment (p < 0.001). The level of NO was substantially higher in patients with rDD compared to CG. For all examined subjects (p < 0.001), elevated levels of NO in blood plasma adversely affect the efficiency of visual-spatial and auditory-verbal working memory as well as short-term declarative memory. For rDD patients, elevated NO levels were associated with worse cognitive test performance. The higher was the concentration of plasma NO, the greater was the severity of depressive symptoms measured by HDRS (p = 0.03). Conclusions: (1) Higher concentration of plasma NO in rDD patients is associated with the severity of depressive symptoms. (2) Elevated levels of plasma NO are related to impairment of visual-spatial and auditory-verbal working memory as well as to impairment of short-term declarative memory. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:127 / 131
页数:5
相关论文
共 50 条
  • [41] Cognitive Decline and Its Associated Factors in Patients with Major Depressive Disorder
    Ab Latiff, Husni Zaim
    Ariaratnam, Suthahar
    Shuib, Norley
    Isa, Mohamad Rodi
    HEALTHCARE, 2023, 11 (07)
  • [42] Cognitive impairment in major depressive disorder and severe depressive episode with psychotic symptoms
    Fedorova, S.
    Blazkova, M.
    Humpolicek, P.
    Bartecek, R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S143 - S144
  • [43] Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults
    Diniz, Breno S.
    Vieira, Erica M.
    Mendes-Silva, Ana Paula
    Bowie, Christopher R.
    Butters, Meryl A.
    Fischer, Corinne E.
    Flint, Alastair
    Herrmann, Nathan
    Kennedy, James
    Lanctot, Krista L.
    Mah, Linda
    Pollock, Bruce G.
    Mulsant, Benoit H.
    Rajji, Tarek K.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)
  • [44] Cognitive Deficits in Patients of Depressive Disorder
    Jat, Muhammad Ilyas
    Rajper, Ali Bux
    Lal, Chooni
    Washdev
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2022, 21 (01): : 60 - 64
  • [45] Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients
    Lampe, IK
    Sitskoorn, MM
    Heeren, TJ
    PSYCHIATRY RESEARCH, 2004, 125 (02) : 73 - 79
  • [46] Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder
    Gao, Shang-Feng
    Lu, Yun-Rong
    Shi, Li-Gen
    Wu, Xue-Yan
    Sun, Bo
    Fu, Xin-Yan
    Luo, Jian-Hong
    Bao, Ai-Min
    PSYCHONEUROENDOCRINOLOGY, 2014, 47 : 136 - 140
  • [47] Functional impairment in patients with major depressive disorder
    Lam, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1129 - S1129
  • [48] Rapid screening for perceived cognitive impairment in major depressive disorder
    Iverson, Grant L.
    Lam, Raymond W.
    ANNALS OF CLINICAL PSYCHIATRY, 2013, 25 (02) : 135 - 140
  • [49] Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder
    McIntyre, Roger S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (09) : E1427 - +
  • [50] Cognitive impairments in patients with depressive disorder and bipolar disorder
    Kim, H. C.
    Kim, M. K.
    Lee, E. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S323 - S323